Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-025065
Filing Date
2026-07-30
Accepted
2026-07-30 16:22:12
Documents
76
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20260630_10q.htm   iXBRL 10-Q 1513819
2 EXHIBIT 31.1 ex_988819.htm EX-31.1 8743
3 EXHIBIT 31.2 ex_988820.htm EX-31.2 9319
4 EXHIBIT 32.1 ex_988821.htm EX-32.1 4638
5 EXHIBIT 32.2 ex_988822.htm EX-32.2 3890
  Complete submission text file 0001437749-26-025065.txt   8366070

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sdev-20260630.xsd EX-101.SCH 75146
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdev-20260630_def.xml EX-101.DEF 534164
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdev-20260630_lab.xml EX-101.LAB 431133
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdev-20260630_pre.xml EX-101.PRE 564827
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sdev-20260630_cal.xml EX-101.CAL 32690
80 EXTRACTED XBRL INSTANCE DOCUMENT nby20260630_10q_htm.xml XML 1420495
Mailing Address 222 LAKEVIEW AVE, SUITE 800 WEST PALM BEACH FL 33401
Business Address 222 LAKEVIEW AVE, SUITE 800 WEST PALM BEACH FL 33401 561-206-4345
Stablecoin Development Corp (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 261223633
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)